ClinicalTrials.Veeva

Menu

Assessment of Vitamin B12 Bioavailability From Egg

U

USDA, Western Human Nutrition Research Center

Status

Completed

Conditions

Bioavailability of Vitamin B12 From Chicken Eggs

Study type

Observational

Funder types

Other U.S. Federal agency

Identifiers

NCT01366937
200715660-2

Details and patient eligibility

About

The hypothesis of this study is that chicken eggs can be enriched in vivo with 14C-B12 and fed to healthy human subjects to determine B12 bioavailability from eggs.

The goal of this research is to enrich eggs in vivo with radioactively labeled vitamin B12 to a level that allows us to feed the enriched eggs to humans and determine how much of the vitamin B12 is digested and absorbed into the body. This will tell us if eggs are a good dietary source of vitamin B12. Importantly, sensitive technology available at the Lawrence Livermore National Laboratories allows us to measure very low amounts of radioactive vitamin B12. This allows us to do this experiment with a level of radioactive B12 that is not harmful to animals or humans. The results of the investigators first experiment indicate that the investigators can inject radioactively labeled vitamin B12 into a laying hen and detect the radioactive vitamin B12 in the eggs at a level sufficient for feeding to humans in a bioavailability study.

Enrollment

10 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • normal healthy subjects, adequate B12 status and absorptive capacity and the availability to complete the protocol.

Exclusion criteria

  • any chronic health disorder, anemia of any kind, renal insufficiency, and pregnancy or lactation.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems